Position in BMRN
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$903,840
-$47,040 QoQ
Shares Held
16,000
0.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Banque Cantonale Vaudoise holds $13,170,474 across 21 Biotechnology names. BMRN ranks #4 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,927 | $3,986,262 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,978 | $1,977,940 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,970 | $1,522,100 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
16,000 | $903,840 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
17,463 | $830,714 | |
| 6 | INSM |
INSMED Inc
|
3,923 | $641,488 | |
| 7 | SMMT |
Summit Therapeutics Inc.
|
23,916 | $453,447 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
862 | $451,231 |
All Filings in BMRN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $903,840 | 16,000 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $950,880 | 16,000 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $866,560 | 16,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $879,520 | 16,000 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,131,040 | 16,000 | Shares | Sole | 2025-05-08 | |
| 2024-09-30 | $1,124,640 | 16,000 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,346,095 | 16,350 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,428,009 | 16,350 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $1,616,384 | 16,764 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,737,216 | 19,634 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,748,335 | 20,170 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,966,192 | 20,220 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $2,485,829 | 24,020 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,718,966 | 20,278 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,637,179 | 19,756 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $1,577,157 | 20,456 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,807,287 | 20,456 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,655,397 | 21,418 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $493,797 | 5,918 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $629,224 | 8,333 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,237,393 | 14,111 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $965,987 | 12,697 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $1,820,621 | 14,761 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $608,738 | 7,204 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||